Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Starting treatment news

Show

From To
Starting HIV therapy with a viral load above 100,000 is associated with a lower chance of achieving an undetectable viral load

Starting HIV treatment with a viral load above 100,000 copies/ml is associated with a reduced chance of achieving an undetectable viral load within 48 weeks regardless of

Published
28 November 2012
By
Michael Carter
Abacavir: new studies challenge the evidence of reduced potency when viral load is high

An analysis of two studies of the new HIV integrase inhibitor dolutegravir presented at the Eleventh International Congress on Drug Therapy in HIV Infection in Glasgow had

Published
26 November 2012
By
Gus Cairns
New fixed-dose combination pills measure up to Atripla - corrected version*

Several studies, or updates of studies, comparing newer against older drug regimens were presented at the Eleventh International Congress on Drug Therapy in HIV Infection last week.

Published
20 November 2012
By
Gus Cairns
Death rates elevated at all CD4 counts below 500 in sub-Saharan Africa

A comparison of death rates between the HIV-positive and HIV-negative partners in serodiscordant couples in sub-Saharan Africa has found significantly higher death rates in people with HIV

Published
06 November 2012
By
Keith Alcorn
South Africa: Surviving On an Empty Stomach

Nombulelo Manala Lubhelu (45) of Lusikisiki-kwaGqwarhu location has taken the tough decision of declining lifesaving antiretrovirals (ARVs) because she is simply too poor to buy food and does not want to take her medication on an empty stomach.

Published
31 October 2012
From
AllAfrica
The generic generation

In the next few years, some of the most widely used HIV drugs will come off patent in the UK. Gus Cairns asks: what are the

Published
22 October 2012
From
HIV treatment update
High-dose multivitamins have no benefit for people starting HIV treatment but cause serious liver disturbances

Taking high-dose multivitamins has no health benefits for people starting antiretroviral therapy, but causes serious disturbances in liver function, according to the results of a large randomised trial

Published
17 October 2012
By
Michael Carter
Diverse factors influence choice of first ART regimen in Swiss study

enofovir/emtricitabine (TDF/FTC) plus efavirenz was by far the most popular first-line antiretroviral therapy (ART) among Swiss HIV Cohort Study (SHCS) members starting treatment from January 2005 through December 2009. An AIDS diagnosis and a higher viral load favored prescription of the second most popular regimen, TDF/FTC plus lopinavir/ritonavir.

Published
09 October 2012
From
International AIDS Society
Starting HIV treatment reduces the risk of serious non-AIDS-related diseases

Serious non-AIDS-defining illnesses are common in people recently diagnosed with HIV, Spanish investigators report in the online edition of AIDS. “Clinicians should be aware that during the initial

Published
09 October 2012
By
Michael Carter
CD4 Counts Not Affected by Alcohol Consumption

Consuming alcohol doesn’t appear to have a deleterious effect on CD4 cell counts among people living with HIV receiving antiretroviral  therapy, according to a new Johns Hopkins University study.

Published
25 September 2012
From
AIDSMeds

Filter by country